Abstract:AIM: To determine the prevalence of Helicobacter pylori (H. pylori) infection, the serum anti-H. pylori immunoglobulin G (IgG) and IgA antibody responses, and the value of clinical presentations in diagnosis of H. pylori infection in patients with gastric atrophy, intestinal metaplasia and dysplasia. METHODS: H. pylori infection was detected by histology in 209 patients with mild chronic atrophic gastritis (CAG, n=76), severe CAG (n=22), mild intestinal metaplasia (IM, n=22), severe IM (n=58), or dysplasia (DYS, n=31). Serum anti-H. pylori IgG and IgA were double sampled and evaluated by enzyme-linked immunoadsordent assays. 35 clinical presentations were observed and their relationship with H. pylori infection was analyzed by the k-means cluster method. RESULTS: Both IgG and IgA levels in H. pylori positive patients were significantly higher than those negative for H. pylori(P<0.001-0.01). The prevalence of H. pylori was highest in severe IM (84.5 %), and lowest in mild CAG (51.3 %) (P<0.01). They were similar in severe CAG (68.2 %), mild IM (72.7 %), and DYS (67.7 %). In H. pylori positive patients, the IgG levels in severe CAG were significantly higher than those in mild CAG (P<0.01). In H. pylori negative patients, both IgG and IgA levels increased remarkably in severe IM, compared to those in mild IM (P<0.01-0.05). H. pylori infection exhibited no association with patient's gender (62.1 % in males; 71.7 % in females) and age (r=0.0814, P=0.241). The diagnostic accuracy based on 35 clinical presentations was 65.7 %. It could be improved by 5.7 % when only the assemblage of digestive symptoms were engaged, or by 8.6 % when the pathogenic factors, general status and grossoscopy were combined. The diagnostic accuracy could be decreased when only the general symptoms were engaged, or when the pathogenic factors were accompanied with some common digestive symptoms. CONCLUSION: H. pylori infection is a major risk factor for the process from atrophy, IM to DYS of gastric mucosa. Serum IgG and IgA are good indicators to evaluate this progress with a certain arrearage. Investigation on the effective assemblages of clinical presentations may provide a better understanding in the pathogenesis, diagnosis and treatment for H. pylori infection.

Clinical study on effect of Helicobacter py lori infection on levels of IL-6 and IL-8 in serum,gastric juice,and tissues of gastric cancer patients

Study on the Serum Levels of Soluble Intercellular Adhesion Molecule-1 (Sicam-1) in Patients with Helicobacter Pylori Infection

Correlation Analysis of Serum Pepsinogen, Interleukin, and TNF-α with Hp Infection in Patients with Gastric Cancer: A Randomized Parallel Controlled Clinical Study

Association of Helicobacter Pylori Infection and Serum Pepsinogen with Chronic Gastric Diseases and Gastric Cancer

Study on Relationship Between Infection of Helicobacter Pylori,caga-Hp,and Gastric Diseases

Study on the Gastic Leptin and Helicobacter Pylori Associated Gastritis

Helicobacter pylori infection, H19 and LINC00152 expression in serum and risk of gastric cancer in a Chinese population

Multi-groups controled study on the association of Helicobacter pylori infection with gastric cancer and stomach diseases

[Significance of serum level of NO and IL-8 in Helicobacter pylori associated gastric diseases]

Influence of Helicobacter pylori Infection on Diagnostic Performance of Serum Pepsinogens

Effect of <i>Helicobacter pylori</i> on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer

Changes of Serum Level of Th1/Th2 Cellular factors and Helicobacter Pylori (Hp)-induced Gastric Carcinoma

Effect of Helicobacter Pylori Infection on Gastric Epithelial Proliferation in Progression from Normal Mucosa to Gastriccarcinoma.

Characterization of Helicobacter pylori-infected gastric microbiota

Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of H. pylori infection in patients with precancerous lesions.

[Effect of Helicobacter Pylori on Gastric Mucosal Cell Proliferation in Gastritis].

Expression of P53 and iNOS in patients with Helicobacter pylori-associated gastric diseases

Study on Relationship Between Infection of Helicobacter Pylori,caga~+-Hp and Gastric Diseases

Helicobacter Pylori Blood Biomarkers and Gastric Cancer Survival in China

Differential cytokine expression in gastric tissues highlights helicobacter pylori's role in gastritis

Progress of Study on the Eradication of Helicobacter Pylori Infection and Gastric Cancer